Clinical  	Clinical  	 JJ	B-NP
characteristics  	characteristics  	 NNS	I-NP
of  	of  	 IN	O
resistant  	resistant  	 JJ	O
hypertension  	hypertension  	 NN	O
in  	in  	 IN	O
renal  	renal  	 JJ	B-NP
transplant  	transplant  	 NN	I-NP
patients  	patients  	 NNS	I-NP
Hypertension  	Hypertension  	 NNP	O
is  	is  	 VBZ	O
a  	a  	 DT	O
prevalent  	prevalent  	 JJ	O
complication  	complication  	 NN	B-NP
that  	that  	 WDT	O
occurs  	occurs  	 VBZ	O
in  	in  	 IN	O
80-85 	80-85 	 CD	O
%  	%  	 NN	O
of  	of  	 IN	O
all  	all  	 DT	O
kidney  	kidney  	 NN	O
transplant  	transplant  	 NN	O
recipients 	recipients 	 NNS	O
.  	.  	 .	O
The  	The  	 DT	O
pathogenesis  	pathogenesis  	 NN	B-NP
of  	of  	 IN	I-NP
post-transplant  	post-transplant  	 JJ	I-NP
hypertension  	hypertension  	 NN	I-NP
is  	is  	 VBZ	O
multifactorial  	multifactorial  	 VBN	O
and  	and  	 CC	O
includes  	includes  	 VBZ	O
pre-transplant  	pre-transplant  	 JJ	B-NP
hypertension 	hypertension 	 NN	I-NP
,  	,  	 ,	O
donor  	donor  	 JJ	B-NP
hypertension 	hypertension 	 NN	I-NP
,  	,  	 ,	O
renin  	renin  	 JJ	B-NP
secretion  	secretion  	 NN	I-NP
from  	from  	 IN	O
the  	the  	 DT	O
native  	native  	 JJ	O
kidney 	kidney 	 NN	O
,  	,  	 ,	O
graft  	graft  	 JJ	B-NP
dysfunction 	dysfunction 	 NN	I-NP
,  	,  	 ,	O
recurrent  	recurrent  	 JJ	O
disease  	disease  	 NN	O
and  	and  	 CC	O
immunosuppressive  	immunosuppressive  	 JJ	B-NP
treatment 	treatment 	 NN	I-NP
.  	.  	 .	O
Hypertension  	Hypertension  	 NNP	O
negatively  	negatively  	 RB	O
affects  	affects  	 JJ	O
transplant  	transplant  	 NN	B-NP
and  	and  	 CC	O
patient  	patient  	 JJ	O
survival  	survival  	 NN	B-NP
outcomes 	outcomes 	 NNS	I-NP
;  	;  	 :	O
cardiovascular  	cardiovascular  	 JJ	B-NP
disease  	disease  	 NN	I-NP
( 	( 	 -LRB-	O
CVD 	CVD 	 NNP	B-NP
)  	)  	 -RRB-	O
is  	is  	 VBZ	O
the  	the  	 DT	O
leading  	leading  	 JJ	O
cause  	cause  	 NN	O
of  	of  	 IN	O
morbidity  	morbidity  	 NN	O
and  	and  	 CC	O
mortality  	mortality  	 NN	O
in  	in  	 IN	O
patients  	patients  	 NNS	O
with  	with  	 IN	O
chronic  	chronic  	 JJ	B-NP
renal  	renal  	 JJ	I-NP
disease  	disease  	 NN	I-NP
and  	and  	 CC	O
after  	after  	 IN	O
successful  	successful  	 JJ	O
renal  	renal  	 JJ	B-NP
transplantation 	transplantation 	 NN	I-NP
.  	.  	 .	O
Hypertension  	Hypertension  	 NNP	O
is  	is  	 VBZ	O
a  	a  	 DT	O
well-known  	well-known  	 JJ	O
risk  	risk  	 NN	B-NP
factor  	factor  	 NN	I-NP
for  	for  	 IN	I-NP
CVD  	CVD  	 NNP	I-NP
and  	and  	 CC	O
it  	it  	 PRP	O
is  	is  	 VBZ	O
frequently  	frequently  	 RB	O
associated  	associated  	 VBN	O
with  	with  	 IN	O
other  	other  	 JJ	O
CVD  	CVD  	 NNP	B-NP
risk  	risk  	 NN	I-NP
factors 	factors 	 NNS	I-NP
.  	.  	 .	O
Despite  	Despite  	 IN	O
increased  	increased  	 JJ	O
awareness  	awareness  	 NN	O
of  	of  	 IN	O
the  	the  	 DT	O
adverse  	adverse  	 JJ	O
effects  	effects  	 NNS	O
of  	of  	 IN	O
hypertension  	hypertension  	 NN	O
in  	in  	 IN	O
both  	both  	 DT	O
graft  	graft  	 NN	O
and  	and  	 CC	O
patient  	patient  	 JJ	O
survival 	survival 	 NN	O
,  	,  	 ,	O
long-term  	long-term  	 JJ	O
studies  	studies  	 NNS	O
have  	have  	 VBP	O
shown  	shown  	 VBN	O
that  	that  	 IN	O
arterial  	arterial  	 JJ	B-NP
hypertension  	hypertension  	 NN	I-NP
in  	in  	 IN	O
the  	the  	 DT	O
transplant  	transplant  	 NN	B-NP
population  	population  	 NN	I-NP
has  	has  	 VBZ	O
not  	not  	 RB	O
been  	been  	 VBN	O
adequately  	adequately  	 RB	O
controlled 	controlled 	 VBN	O
.  	.  	 .	O
Resistant  	Resistant  	 JJ	B-NP
hypertension  	hypertension  	 NN	I-NP
( 	( 	 -LRB-	O
RH 	RH 	 NNP	B-NP
)  	)  	 -RRB-	O
is  	is  	 VBZ	O
defined  	defined  	 VBN	O
as  	as  	 IN	O
office  	office  	 NN	B-NP
blood  	blood  	 NN	I-NP
pressure  	pressure  	 NN	I-NP
( 	( 	 -LRB-	O
oBP 	oBP 	 NNP	B-NP
)  	)  	 -RRB-	O
that  	that  	 WDT	O
remains  	remains  	 VBZ	O
above  	above  	 IN	O
goal  	goal  	 NN	O
( 	( 	 -LRB-	O
oBP  	oBP  	 NNP	B-NP
≥  	≥  	 CD	O
140 	140 	 CD	O
/ 	/ 	 CD	O
90  	90  	 CD	O
or  	or  	 CC	O
130 	130 	 CD	O
/ 	/ 	 CD	O
80  	80  	 CD	O
mmHg 	mmHg 	 NN	B-NP
)  	)  	 -RRB-	O
in  	in  	 IN	O
patients  	patients  	 NNS	O
with  	with  	 IN	O
diabetes  	diabetes  	 NN	O
or  	or  	 CC	O
chronic  	chronic  	 JJ	B-NP
kidney  	kidney  	 NN	I-NP
disease  	disease  	 NN	I-NP
despite  	despite  	 IN	O
the  	the  	 DT	O
concurrent  	concurrent  	 JJ	O
use  	use  	 NN	O
of  	of  	 IN	O
three  	three  	 CD	O
antihypertensive  	antihypertensive  	 CD	B-NP
agents 	agents 	 NNS	I-NP
,  	,  	 ,	O
at  	at  	 IN	O
full  	full  	 JJ	O
doses 	doses 	 NNS	O
,  	,  	 ,	O
one  	one  	 CD	O
of  	of  	 IN	O
them  	them  	 PRP	O
being  	being  	 VBG	O
a  	a  	 DT	O
diuretic 	diuretic 	 NN	B-NP
.  	.  	 .	O
Despite  	Despite  	 IN	O
studies  	studies  	 NNS	O
in  	in  	 IN	O
the  	the  	 DT	O
general  	general  	 JJ	O
population  	population  	 NN	O
and  	and  	 CC	O
the  	the  	 DT	O
high  	high  	 JJ	O
prevalence  	prevalence  	 NN	O
of  	of  	 IN	O
hypertension  	hypertension  	 NN	O
in  	in  	 IN	O
renal  	renal  	 JJ	B-NP
transplant  	transplant  	 NN	I-NP
patients 	patients 	 NNS	I-NP
,  	,  	 ,	O
data  	data  	 NNS	O
about  	about  	 IN	O
RH  	RH  	 NNP	B-NP
are  	are  	 VBP	O
very  	very  	 RB	O
scarce  	scarce  	 JJ	O
and  	and  	 CC	O
the  	the  	 DT	O
prevalence  	prevalence  	 NN	O
of  	of  	 IN	O
RH  	RH  	 NNP	B-NP
in  	in  	 IN	O
renal  	renal  	 JJ	B-NP
transplant  	transplant  	 NN	I-NP
patients  	patients  	 NNS	I-NP
is  	is  	 VBZ	O
unknown  	unknown  	 JJ	O
and  	and  	 CC	O
could  	could  	 MD	O
be  	be  	 VB	O
associated  	associated  	 VBN	O
with  	with  	 IN	O
a  	a  	 DT	O
worse  	worse  	 JJR	B-NP
prognosis 	prognosis 	 NN	I-NP
.  	.  	 .	O
